FTDR vs GILD · P/E 18, rev $1.84B vs P/E 18, rev $29.44B
Frontdoor Inc (FTDR) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Frontdoor Inc (FTDR) is a personal services company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FTDR revenue for 2024-12-31 was $1.84B. Net income was $235.0M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. FTDR currently screens at market cap $4.47B and trailing P/E 18.2.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FTDR currently screens at market cap $4.47B and trailing P/E 18.2. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FTDR and GILD stock pages for the full models.
Not investment advice.